Prognos Health

Prognos Health operates a healthcare data and artificial intelligence platform focused on clinical diagnostics. The company was originally founded in 2010 (under the name Predictive Health, later rebranded to Prognos), and is headquartered in New York, NY. It aggregates and analyzes laboratory test results and other clinical data to identify disease patterns earlier in the care continuum.

The company's platform is used by pharmaceutical companies, life sciences organizations, and healthcare payers to support clinical development, patient identification, and disease progression modeling. Prognos maintains a large registry of de-identified clinical diagnostic and lab data, drawing from laboratory networks and electronic health record sources across the United States, and applies machine learning models to detect early indicators of conditions such as chronic kidney disease, cancer, and autoimmune disorders.

Prognos Health has raised capital across multiple funding rounds from investors including Merck Global Health Innovation Fund, Safeguard Scientifics, and other healthcare-focused venture investors. The company has grown through data partnerships with diagnostic laboratories and health systems to expand the scale of its clinical data registry.